Holocene Advisors
GWPH

Holocene Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Holocene Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-206,743
Closed -$18.1M – 844
2020
Q1 		$18.1M Sell
206,743
-140,375
-40% -$14.9M 0.19% 129
2019
Q4 		$36.3M Buy
347,118
+89,674
+35% +$10.1M 0.33% 95
2019
Q3 		$29.6M Buy
+257,444
New +$39.1M 0.3% 92

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Holocene Advisors's GWPH Position: Q2 2020 in Review

Holocene Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 206,743 shares — an estimated $18.1M sold.

Holocene Advisors first reported a position in GWPH in Q3 2019 and held it in 3 quarters. The position peaked at $36.3M in Q4 2019. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

  • Holocene Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • Holocene Advisors sold 206,743 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $18.1M.
  • Holocene Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2019 and held it in 3 quarters.
  • Holocene Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $36.3M in Q4 2019.
  • 299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on Holocene Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.